Global scale CHAI operates in 36 countries with broad reach and a track record of negotiating price reductions for vaccines, medical devices, and diagnostics, presenting a wide market for scalable supply and procurement partnerships.

Public-private Active collaboration with governments and private sector partners across health programs creates multiple entry points for alliance-driven sales, including supply chain optimization tools, testing kits, and affordable therapeutics.

Cost reduction Recent partnerships and announced price reductions for TB screening software and diagnostics suggest a customer need for low-cost, high-impact health tech solutions and monitoring platforms in LMIC markets.

Technology leverage CHAI’s tech stack and recent launches in global monitoring platforms indicate interest in analytics, data-driven decision support, and AI-enabled screening tools—areas where innovative health tech vendors can add value.

Funding readiness With revenue scale and involvement in funding-focused initiatives and philanthropic partnerships, CHAI is well-positioned to pursue grants, co-funded programs, and multi-stakeholder procurement collaborations for new health investments.